• Nachrichtendetail
• 

31.05.2024 07:04:41 - dpa-AFX: *REGENERON: FDA EXTENDS TARGET ACTION DATE OF SBLA FOR DUPIXENT FOR COPD PATIENTS WITH TYPE 2 INFLAMMATION BY THREE MONTHS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	Regeneron Pharmaceuticals	881535	NASDAQ	1.092,090	16.07.24 20:04:13	+9,980	+0,92%	1.092,020	1.093,920	1.097,290	1.082,110